Presentation “DNA Damage Response and Tumor Metastasis” to be Presented April 7, 2014 at ESTRO 33, the Premier European Event in Radiation Oncology
Birmingham, Ala. – Southern Research Institute today announced that the Institute’s translational radiation oncology research program in the Drug Discovery Division has been invited to present at a symposium during the European Society of Radiotherapy and Oncology (ESTRO) 33rd annual meeting being held in Vienna, Austria, April 4 – 8, 2014. Bo Xu, M.D., Ph.D., Chair, Oncology Research Department, Southern Research Institute, will speak at the conference, which attracts leading scientists from around the world, on April 7, in a clinical science symposium entitled: “DNA Damage Response and Tumor Metastasis”.
“We are proud to participate in the ESTRO 33 meeting, and pleased to have this important research recognized internationally at such a prestigious event,” said Mark J. Suto, Ph.D., Vice President, Drug Discovery Division, Southern Research Institute. The translational radiation oncology program led by Dr. Xu aims to understand molecular mechanisms of the DNA damage response and to develop molecularly targeted drugs to enhance the effectiveness of radiation therapy, a major treatment modality that almost two-third of cancer patients will need during the process of treatment. The molecular radiobiology laboratory is a part of the Cancer Research Program at Southern Research which has a long and successful history of oncology drug discovery.
To access information about the presentation and the ESTRO 33 meeting, go to the ESTRO 33 website: http://www.estro.org/congresses-meetings/items/estro-33.
About Southern Research Institute
Southern Research Institute is a not-for-profit 501(c)(3) scientific research organization founded in 1941 that conducts preclinical drug discovery and development, advanced engineering research in materials, systems development, and environment and energy research. Approximately 500 scientific and engineering team members support clients and partners in the pharmaceutical, biotechnology, defense, aerospace, environmental and energy industries. Southern Research is headquartered in Birmingham, AL, with additional laboratories and offices in Wilsonville and Huntsville, AL, Frederick, MD, Durham, NC, Houston, TX, and Cartersville, GA. For more information visit: http://southernresearch.org.